¼¼°èÀÇ ÀǾàǰ ºÎÇüÁ¦ ½ÃÀå(-2029³â)
Excipients in Pharmaceuticals: Global Markets to 2029
»óǰÄÚµå : 1563137
¸®¼­Ä¡»ç : BCC Research
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 105 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,650 £Ü 6,380,000
PDF & Excel (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,580 £Ü 7,656,000
PDF & Excel (2-5 Users) help
PDF ¹× Excel º¸°í¼­¸¦ 2-5¸íÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,696 £Ü 9,187,000
PDF & Excel (Site License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,035 £Ü 11,024,000
PDF & Excel (Enterprise License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°è ÀǾàǰ ºÎÇüÁ¦ ½ÃÀå ±Ô¸ð´Â 2023³â 92¾ï ´Þ·¯, 2024³â 97¾ï ´Þ·¯¿¡¼­ ¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ 5.1% ¼ºÀåÇÏ¿© 2029³â ¸»¿¡´Â 124¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À¯±â ºÎÇüÁ¦ ºÎ¹®Àº 2024³â 87¾ï ´Þ·¯¿¡¼­ 5.2%ÀÇ CAGR·Î 2029³â ¸»¿¡´Â 112¾ï ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹«±â ÀǾàǰ ºÎÇüÁ¦ ºÎ¹®Àº 2024³â 7¾ï 1,630¸¸ ´Þ·¯¿¡¼­ 2029³â ¸» 8¾ï 6,170¸¸ ´Þ·¯·Î 3.8%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è ÀǾàǰ ºÎÇüÁ¦ ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ¿µÇâ¿äÀÎ ¹× ½ÃÀå ±âȸ ºÐ¼®, ±ÔÁ¦ ȯ°æ, ½ÅÈï ±â¼ú ¹× ±â¼ú°³¹ß µ¿Çâ, ½ÃÀå ±Ô¸ð ÃßÁ¤ ¹× ¿¹Ãø, °¢Á¾ ºÎ¹®º°¡¤Áö¿ªº° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

Á¦3Àå ½ÃÀå ¿ªÇÐ

Á¦4Àå ½Å±â¼ú°ú °³¹ß

Á¦5Àå ¼¼°èÀÇ ÀǾàǰ ÷°¡Á¦ ½ÃÀå

Á¦6Àå °æÀï Á¤º¸

Á¦7Àå ÀǾàǰ ÷°¡Á¦ ½ÃÀåÀÇ Áö¼Ó°¡´É¼º : ESG °üÁ¡

Á¦8Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global market for pharmaceutical excipients was valued at $9.2 billion in 2023. It is expected to grow from $9.7 billion in 2024 to $12.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2029.

The global market for organic excipients is expected to grow from $8.7 billion in 2024 to $11.2 billion by the end of 2029, at a CAGR of 5.2% from 2024 to 2029.

The global market for inorganic pharmaceutical excipients is expected to grow from $716.3 million in 2024 to $861.7 million by the end of 2029, at a CAGR of 3.8% from 2024 to 2029.

Report Scope

This report provides a comprehensive summary of pharmaceutical excipients, along with a discussion of the competitive landscape and profiles of key market players that highlight revenues, product portfolios, and recent activities. The report analyzes trends and dynamics, including drivers, limitations, challenges and opportunities. This research study discusses historical, current and potential market size. The report will enable market players and new entrants to make informed decisions about the production and licensing of goods and services. Organizations, distributors and exporters will find useful information about market developments and trends. The report segments the market by three product types: organic, inorganic or water that meets the standards of the U.S. Pharmacopeia (USP). Regional and country-level market analysis is provided for all the major segments. The market excludes the excipients used in the cosmetics, food and beverage, and chemical industries.

The market is divided into segments as follows:

By excipient material type:

By organic type:

By inorganic type:

By dosage form:

By administration route:

Oral.

By end user:

For each area, for the base year of 2023, BCC Research identified the current products in the market as well as market drivers; measured the current market size; quantified current company market shares; and made forecasts for 2029.

Report Includes

Table of Contents

Chapter 1 Executive Summary

Chapter 2 Market Overview

Chapter 3 Market Dynamics

Chapter 4 Emerging Technologies and Developments

Chapter 5 Global Market for Pharmaceutical Excipients

Chapter 6 Competitive Intelligence

Chapter 7 Sustainability in the Market for Pharmaceutical Excipients: An ESG Perspective

Chapter 8 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â